Dow Down 0.18% Nasdaq Down 0.33%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
9.31 0.05(0.53%) Oct 29, 4:00PM EDT
Prev Close:9.36
Open:9.35
Bid:8.91 x 1800
Ask:9.31 x 100
1y Target Est:14.57
Beta:2.39
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:9.06 - 9.45
52wk Range:6.88 - 18.18
Volume:762,908
Avg Vol (3m):1,305,010
Market Cap:1.15B
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HALODown 0.53%1.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.61
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback